200 Million More Reasons to Buy Pfizer Stock

·3-min read
200 Million More Reasons to Buy Pfizer Stock

Second, Pfizer offers an attractive dividend that currently yields north of 3.7%. If you need more than just a relatively low valuation and a fantastic dividend, there are now 200 million more reasons to buy Pfizer stock. Pfizer and its partner BioNTech (NASDAQ: BNTX) announced last week that the U.S. government has bought an additional 200 million doses of its COVID-19 vaccine.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting